Results for all evidence | Prescribing and Technical Information | Scottish Medicines Consortium - SMC 1 - 10 of 1715 sorted by relevance / date

Indication: Acute coronary syndromes

Indication: Anticoagulant in patients undergoing percutaneous coronary intervention

Indication: Treatment of chronic hepatitis C (HCV) genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients with compensated liver disease who have failed...

Indication: In combination with rituximab, cyclophosphamide, doxorubicin and prednisone for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for...

Indication: Treatment of chronic hepatitis C (HCV) genotype 1 infection, in combination with peginterferon and ribavirin, in adult patients with compensated liver disease who are previously untreated.

Indication: In combination with dexamethasone, or with dexamethasone and thalidomide, for the induction treatment of adult patients with previously untreated multiple myeloma who are eligible for...

Indication: For the treatment of multiple meyeloma (2 indications).

Indication: Progressive multiple myeloma (MM)

Indication: Multiple myeloma

Indication: Multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplantation